Ozempic, Wegovy, Mounjaro: Are GLP-1 drugs weight loss wonders or health gamble?

India, home to the world’s largest low- and middle-income (LMIC) population, is now facing a weighty challenge — literally. It accounts for a staggering 15% of the global obesity burden, and by 2040, almost half of the Indian population is projected to be overweight or obese. The latest National Family Health Survey (NFHS-5) reveals a worrying trend: one in five Indian households has all adults classified as overweight, and in one in ten, all